Ebola Vaccine Makers Get Liability Immunity From HHS
Law360, New York (December 9, 2014, 3:42 PM EST) -- The U.S. Department of Health and Human Services said on Tuesday that it is extending liability protections to makers of experimental Ebola vaccines, including GlaxoSmithKline PLC, hoping to spur the global development of vaccines to fight the ongoing epidemic in West Africa.
HHS Secretary Sylvia M. Burwell made the declaration under the Public Readiness and Emergency Preparedness Act of 2005, giving vaccine manufacturers immunity against liability claims stemming from the development, testing, distribution and administration of three vaccines for the Ebola virus. This immunity will motivate pharmaceutical companies to research and develop these Ebola vaccines and use them in large-scale campaigns...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!